ABSTRACT. Tyrosine hydroxylase (TH) is the rate-limiting enzyme of dopamine (DA) biosynthesis, which is up-regulated by vitamin C administration. Nurr1 gene is highly expressed in brain and important for midbrain DAergic cell development and survival. But, the role of vitamin C and/or vitamin E during Nurr1 expression is yet to be known. Further, the synergistic effect of vitamins C and E on TH expression has not yet been explored clinically. Therefore, we studied the effects of single or co-administration of vitamin C (0.5 mM) and vitamin E (1 mM) for 72 hr, on both TH and Nurr1 expression in in vitro primary cultured gestational days (GD) 13.5 rat ventral mesencephalon (VM) by Western blot and immunocytochemistry. Our study revealed highest expressions of both TH and Nurr1 in the vitamin C + vitamin E treated group. TH expression was also increased in the vitamin C treated group than that of the control group, but the vitamin E treated group did not show any statistically significant effect. However, both the vitamin C and the vitamin E treated groups revealed increased expression of Nurr1 protein as compared with the control group. The present experimental data suggest that vitamin C can up-regulate the protein expression of TH, but Nurr1 level was elevated either by vitamin C or by vitamin E administration. Further, vitamin E acts synergistically with vitamin C to elevate TH and Nurr1 expression, which is the most novel finding of our study and for the first time; we reported this result, since there have been no published data on the synergistic effect of both the antioxidant vitamins on TH and Nurr1 expression in VM. As the motor function defect due to the progressive loss of DAergic neuron is the major reason of Parkinsonism, therefore, the results of our study finally suggest the effective role of vitamin C and vitamin E during early treatment of Parkinsonism. KEY WORDS: fetal rat mesencephalon, Nurr1, tyrosine hydroxylase, vitamin C, vitamin E.
Vitamin C (ascorbic acid) is well known water soluble antioxidant, which acts as a cofactor in several biochemical reactions, including catecholamine synthesis [8, 12] . Vitamin E (α-tocopherol) is also a powerful antioxidant and serves as an effective free radical scavenger in the brain [1, 5, 7] . It prevents oxidative damage to polyunsaturated lipids in membranes [6, 8] . Since the midbrain dopamine (DA) neurons are generated from the precursor cells in the ventricular zone of the developing ventral mesencephalon (VM), they are the interesting candidate as "donor cell sources" in culture and transplantation studies of dopaminergic (DAergic) neurobiology [9] . However, there is a narrow time window during which VM cells may be effectively harvested; in rats this occurs at early gestational day (GD) of 13.5 to 14.5 [17] .
Nurr1 gene, a member of the nuclear receptor super family of transcription factors, is highly expressed in the central nervous system and important for midbrain DAergic cell development and survival [3, 11, 16, 21] . The onset of Nurr1 expression in the ventral midbrain area also occurs at an early stage of development i.e. GD 10.5, one day prior to the birth of DAergic neurons (GD 11.5) [22] . Backman and coworkers have shown that the majority of mature DA neurons (91%~96%) expresses Nurr1 mRNA in the substantia nigra, ventral tegmental area, retrorubral field and linear nucleus raphe [2] . The profound effect of Nurr1 in the development of ventral DA neurons and its continuous expression during adulthood suggest that this gene may play an essential role not only during development, but also in the maintenance of adult ventral midbrain DAergic neurons [2] .
Tyrosine hydroxylase (TH) is the rate-limiting enzyme of catecholamine biosynthesis and is widely used as a marker of DAergic cells [14] . Yu et al. showed that TH protein level and TH gene expression are drastically up-regulated by vitamin C treatment [20] . Seitz and Shin have also confirmed that TH mRNA expression is increased in vitamin C treated cells by RT-PCR analysis [18, 19] . But, the synergistic effect of vitamins C and E on TH expression has not yet been extensively explored clinically. Further, the role of vitamin C and/or vitamin E during Nurr1 expression, is yet to be known. Therefore, we studied the effects of single or co-administration of vitamin C and vitamin E on both TH and Nurr1 expression in in vitro primary cultured fetal rat VM cells (GD 13.5) and, for the first time, we reported the beneficiary role of the vitamin C and the vitamin E during early treatment of Parkinson's disease (PD).
MATERIALS AND METHODS

Animals and tissue preparation:
Pregnancies were dated by inspection for the vaginal plug, and the day of the plug was defined as GD 0.5. VM tissue was obtained from the GD 13.5 Sprague-Dawley rat fetuses (n=40 fetuses) and then digested in 0.1% trypsin/0.04% DNase/Hanks Balanced Salt Solution (HBSS) at 37°C for 30 min. The tissues were washed with 0.04% DNase in HBSS and then triturated with a fire polished Pasteur pipette to form a dissociated cell suspension. The cells were plated on eight poly-Llysine (50 µg/ml in phosphate buffered saline, PBS)-coated 60 mm dishes at a density of 6.5 × 10 5 cells/dish and cultured in DMEM (Gibco, Grand Island, NY, U.S.A.) containing 26 mM sodium bicarbonate, 20 mM HEPES, 20% fetal calf serum, and 1% antibio-antimycotic solution at 37°C with 5% CO 2 and 95% air for 48 hr. Then, the cells were treated with (1) fresh cell culture media, DMEM (control group), (2) media containing 0.5 mM vitamin C (vitamin C treated group), (3) media containing 1 mM vitamin E (vitamin E treated group), and (4) media containing 0.5 mM vitamin C + 1 mM vitamin E (vitamin C + vitamin E treated group) for 72 hr, respectively. Vitamin C and vitamin E were purchased from Sigma (St. Louis, U.S.A.). All the chemicals were procured from Sigma, unless otherwise specified.
Western Blot Analysis: In vitro cultured VM cells were gently detached with a rubber policeman, washed twice with PBS by spinning in microcentrifuge at 3,000 rpm, and were then homogenized with 100 µl of lysis buffer containing 1% Nonidet P-40(NP-40), 0.1% sodium deoxycholate, 150 mM sodium chloride, 50 mM Tris-hydrochloric acid (pH7.5), 1 mM phenylmethyl sulfonyl fluoride (PMSF), and 0.2 U/ml aprotinin. Lysates were centrifuged at 20,000 g for 10 min at 4°C, frozen in liquid nitrogen, and stored at -80°C until further use. Protein concentrations in supernatants were determined by Bio-Rad protein assay kit using bovine serum albumin as standard. Supernatants from different culture dishes, after minor volume adjustments to provide equal amounts of total proteins (30 µg/lane), were added directly into SDS-sample buffer, boiled, and then applied to a 12.5% SDS-polyacrylamide gel electrophoresis under reducing conditions. After electrophoresis, proteins were transferred to PVDF membrane using the transfer-buffer system (39 mM glycine, 48 mM Tris, 20% methanol and 0.037% SDS electrotransfer) and semidried on electrophoretic transfer cell (15V, 90 min). The PVDF membrane was treated with blocking solution (Tris-buffered saline containing 0.1% (v/ v) Tween 20 (TBST) and 6% (w/v) non-fat dry milk) in order to reduce non-specific binding. Immunoreactions were carried out using primary antibodies in 1:500 dilutions with TBST overnight at 4°C. Rabbit anti-rat TH (Pel-Freez Biologicals, Arokansas, U.S.A.) and Nurr1 (Santa Cruz, California, U.S.A.) polyclonal IgGs were used for this purpose. HRP-conjugated goat anti-rabbit polyclonal IgG (1:1,000 dilutions in TBST; Santa Cruz, California, U.S.A.) was used as secondary antibody. The protein bands were detected using the enhanced chemiluminescence (ECL) detection system (Amersham pharmacia, Buckinghamshise, U.K.) according to the protocol of the manufacturer followed by X-ray exposure. Western blots were analyzed by densitometrically using Sigma Gel software, version 1.0 (Jandel Scientific, San Rafeal, California, U.S.A.).
Immunocytochemistry: Immunocytochemistry was performed on GD 13.5 VM cultures grown in vitro on poly-Dlysine-coated round glass coverslips. Cultures were fixed for 5 min with 4% neutral buffered formaldehyde (NBP), permeabilized in 0.3% Triton X-100 in PBS for 5 min, and rinsed twice in PBS. The cells were preincubated in 10% BSA in PBS for 1 hr at 37°C and washed with 0.02 M PBS for 15 min. Normal goat serum treatment (1:20 dilutions in PBS; Vector, California, U.S.A.) was performed for 90 min at 37°C to block the non-specific binding, followed by overnight incubation at 4°C with primary antibodies in 1:500 dilutions. Rabbit anti-rat TH (Pel-Freez Biologicals, Arokansas, U.S.A.) and rabbit anti-rat Nurr1 (Santa Cruz, California, U.S.A.) primary antibodies were used for the purpose. After treatment with 0.5% periodic acid and biotinylated goat anti-rabbit secondary antibody (1:200 dilutions in PBS; Vector, California, U.S.A.), slides were washed with PBS. Then, the samples were labeled with the avidinbiotinylated peroxidase complex (1:50 dilutions; Vector, California, U.S.A.) for 90 min at 37°C and stained with 3,3'-diaminobenzidine-hydrogen peroxide in PBS for 5 min and washed. Slides were observed under a bright field microscope, and photographed. Further, within the selected area (250 × 250 µm 2 ), TH and Nurr1 immunoreactive cells were counted, and the result was expressed as a percentage of the immunoreactive cells to the all cells counted.
Statistical analysis: All the results were expressed as mean ± standard deviation (SD). One-way ANOVA followed by Tukey-Kramer multiple comparison test were performed using SPSS ® version 10.0 (SPSS Inc, Chicago, U.S.A.), to determine the significance of differences between the relevant groups. In every case, the acceptance level for statistical significance was p<0.05.
RESULTS
Western blot analysis was performed to determine whether the vitamin C and vitamin E treatment had any effect on the expressions of TH and Nurr1 proteins in prenatal rat VM. TH protein was identified in the blots by a single band at 60 kDa. Representative immunoblots for TH were shown in Fig. 1 , where TH protein expression was maximum in the vitamin C + vitamin E treated group (p<0.001), and the second highest expression of TH occurred in the vitamin C treated group (p<0.01) as compared with the control group. Interestingly, TH protein level in the vitamin E treated group was not statistically significant from that of the control group. Further, TH protein levels were significantly increased in both the vitamin C and the vitamin C + vitamin E treated groups while comparing with the vitamin E treated group (p<0.001). Moreover, our study also revealed that TH expression in the vitamin C treated group was markedly decreased than that of the vitamin C + vitamin E treated group (p<0.05).
Nurr1 protein was expressed in the blots at 91 kDa. Nurr1 protein levels were significantly increased in the vitamin C (p<0.05), the vitamin E (p<0.05) and the vitamin C + vitamin E (p<0.001) -treated groups while comparing with the control group (Fig. 2) . Moreover, the vitamin C + vitamin E treated group exhibited a maximum expression of Nurr1 protein among all the study groups (p<0.001 vs. control; p<0.05 vs. vitamin C; p<0.05 vs. vitamin E). However, Nurr1 expression in the vitamin C treated group was not significantly differing from that of the vitamin E treated group. Immunocytochemistry was performed to confirm the expressional changes of TH and Nurr1 proteins in prenatal rat VM with different concentrations of the vitamins, as mentioned above. TH immunoreactivity on GD 13.5 VM was predominantly increased after treatment with vitamin C and vitamin C + vitamin E as compared to the control; however, vitamin E treated group showed very little difference under the same condition (Fig. 3A-D) . We also measured TH immunoreactive cells and as shown by data in Fig. 3E , TH protein immunoreactive cells were significantly increased in the vitamin C (p<0.05 vs. control; p<0.05 vs. vitamin E) and the vitamin C + vitamin E (p<0.001 vs. control; p<0.01 vs. vitamin E; p<0.01 vs. C) treated groups.
Like TH, immunoreactive GD 13.5 rat VM with and without vitamin treatments for Nurr1 was stained in brown color (Fig. 4 A-D) , which showed comparatively less intensity than that of the TH (Fig. 3A-D) . We further represented the Nurr1 results of immunocytochemistry as the quantitative data, which showed significantly high percentage of Nurr1 immunoreactive cells in the vitamin C + vitamin E treated group (p<0.001 vs. control; p<0.05 vs. vitamin C; p<0.05 vs. vitamin E) followed by the vitamin C treated group (p<0.01 vs. control) and the vitamin E treated group (p<0.05 vs. control), respectively (Fig. 4E) .
The immunocytochemistry results (Figs. 3, 4 ) are in agreement with the Western blot results (Figs. 1, 2) , as both revealed the same pattern of response upon vitamins treatments, whether single or co-administration; hence confirmed the effects of the vitamins on GD 13.5 rat VM. 
DISCUSSION
Vitamin C and vitamin E, either alone or in combination, induce TH and Nurr1 proteins expression in the prenatal rat VM:
In agreement with the previous studies [13, [18] [19] [20] , the expression of TH protein was increased in the vitamin C treated group of the present study. To date, although there is no report associated with vitamin E regulation of TH gene, the present study revealed high expression of TH by synergistic action of vitamin E with vitamin C. Moreover, Nurr1 protein levels were not only elevated by the single administration of vitamin C and vitamin E, but also showed the maximal expression by the co-administration of both vitamin C and vitamin E. The previous study further demonstrated the failure of initiation of TH expression in mice in absence of Nurr1 [16, 21] . TH expression is directly regulated by Nurr1 [15] and by vitamin C [18] . Therefore, in accordance with these above-mentioned evidences, our findings implicate that TH expression could be increased along with Nurr1 up-regulation by vitamin C and vitamin E. However, in our study, TH expression was failed to increase in spite of the significant rise in Nurr1 expression in the vitamin E treated group. The true mechanism of the event is unclear. Therefore, further study is needed to elucidate the mechanism.
Vitamin C and vitamin E could provide a benefit for early treatment of parkinson's Disease: We know that motor function defect due to the progressive loss of DAergic neuron in substantia nigra pars compacta is the major reason of Parkinsonism (23). This spatial restriction of the DAergic neurons has provided an opportunity for novel therapeutic approaches, for example, gene therapy, to this disorder (23). Though still it's in infancy, gene therapy refers to the correlation of a disease phenotype through the introduction of new genetic information into the affected organ. Therefore, we studied TH in VM cells, which is the rate-limiting enzyme of DA biosynthesis [14] . We also studied Nurr1, since it is one of the prime members of the nuclear receptor super family of transcription factors and is important for midbrain DAergic cell development and survival [2, 22] . And, the high expression of both TH and Nurr1 was observed in our study upon vitamins treatment.
In clinical practice, particularly neural surgery, both vitamin E and vitamin C serve as antioxidants and thus possess neuroprotective efficacy [1, 5, 7, 8, 20] . Therefore, vitamin C is already used in combination with vitamin E to minimize oxidative stress in the substantia nigra cells of the PD patients [5, 6] . However, the synergistic effect of vitamins C and E on TH expression has not yet been extensively explored clinically. It is only known that the basic treatment of PD involves DA replacement using levodopa (1-3, 4-dihydroxy phenylalanine), a precursor of DA as it readily crosses the blood-brain-barrier [4] . But, its various side effects may pose a significant threat to the patients. Therefore, new treatment regime with low or no side effects should be developed to treat the elderly patients of Parkinsonism. In this context, the present study is very important as it revealed the remarkable expression of TH and Nurr1 in GD 13.5 rat VM upon treatments with vitamin C and vitamin E, whether alone or in combination, suggesting high expression of both TH and Nurr1 could produce large quantity of DA, which provides a protection against degenerative loss of DAergic neuron during Parkinsonism.
CONCLUSION
In conclusion, vitamin C can up-regulate TH and Nurr1 proteins expression in prenatal rat VM. Moreover, vitamin E acts synergistically with vitamin C to elevate TH and Nurr1 expression, which is the most novel finding of our study and for the first time; we reported this result, since there have been no published data on the synergistic effect of both the antioxidant vitamins on TH and Nurr1 expression in VM. Since Parkinsonism is due to the motor function defect associated with DAergic neuronal degeneration in substantia nigra, therefore, our data finally suggest the beneficiary role of antioxidant vitamins i.e. vitamin C and vitamin E during early treatment of PD.
